Maxim Ratnikov is a medicinal chemist specializing in drug discovery, with extensive expertise in structure-based and phenotypic approaches, lab automation, and AI/ML tools. They developed their skills at Novartis, leading projects that advanced multiple clinical candidates, including significant contributions in oncology and infectious diseases. Currently, as an Investigator at the Calibr-Skaggs Institute for Innovative Medicines, they lead projects aimed at combating COVID-19 and advance drug candidates for malaria. With a strong background in business development, Maxim has successfully increased revenue and established automated lab services at Strateos. They hold a PhD in Organic Chemistry from the University of Maryland, where they graduated with a 4.0 GPA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices